PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $30,912,000 | +6.6% | 9,813,602 | -1.5% | 0.00% | 0.0% |
| Q2 2020 | $28,988,000 | +3.2% | 9,961,934 | +0.1% | 0.00% | 0.0% |
| Q1 2020 | $28,080,000 | -19.7% | 9,956,752 | -7.6% | 0.00% | 0.0% |
| Q4 2019 | $34,963,000 | +46.0% | 10,775,002 | -2.8% | 0.00% | 0.0% |
| Q3 2019 | $23,947,000 | -31.0% | 11,085,728 | +0.3% | 0.00% | 0.0% |
| Q2 2019 | $34,711,000 | -24.4% | 11,054,490 | -10.5% | 0.00% | -50.0% |
| Q1 2019 | $45,938,000 | +25.9% | 12,349,088 | -1.9% | 0.00% | 0.0% |
| Q4 2018 | $36,502,000 | +10.9% | 12,586,753 | +0.6% | 0.00% | +100.0% |
| Q3 2018 | $32,913,000 | +0.3% | 12,515,043 | -10.7% | 0.00% | -50.0% |
| Q2 2018 | $32,803,000 | -23.5% | 14,018,452 | -3.9% | 0.00% | 0.0% |
| Q1 2018 | $42,905,000 | +6.4% | 14,593,384 | -0.8% | 0.00% | 0.0% |
| Q4 2017 | $40,311,000 | -15.1% | 14,711,963 | +5.1% | 0.00% | 0.0% |
| Q3 2017 | $47,454,000 | +30.0% | 13,998,813 | -5.3% | 0.00% | 0.0% |
| Q2 2017 | $36,517,000 | +11.8% | 14,784,510 | +2.8% | 0.00% | 0.0% |
| Q1 2017 | $32,655,000 | +26666.4% | 14,384,646 | +24955.6% | 0.00% | – |
| Q4 2016 | $122,000 | -74.6% | 57,411 | -60.0% | 0.00% | -100.0% |
| Q3 2016 | $480,000 | +11.4% | 143,522 | +4.4% | 0.00% | 0.0% |
| Q2 2016 | $431,000 | +524.6% | 137,450 | +566.3% | 0.00% | – |
| Q1 2016 | $69,000 | -60.1% | 20,629 | -58.1% | 0.00% | – |
| Q4 2015 | $173,000 | -29.4% | 49,252 | +1.0% | 0.00% | – |
| Q3 2015 | $245,000 | -47.3% | 48,754 | -32.7% | 0.00% | -100.0% |
| Q2 2015 | $465,000 | -4.1% | 72,429 | +5.0% | 0.00% | 0.0% |
| Q1 2015 | $485,000 | +71.4% | 68,952 | +87.7% | 0.00% | – |
| Q4 2014 | $283,000 | -19.1% | 36,727 | -21.6% | 0.00% | -100.0% |
| Q3 2014 | $350,000 | -2.0% | 46,864 | +26.9% | 0.00% | 0.0% |
| Q2 2014 | $357,000 | +15.9% | 36,917 | -0.1% | 0.00% | – |
| Q1 2014 | $308,000 | +14.1% | 36,956 | +15.8% | 0.00% | – |
| Q4 2013 | $270,000 | +592.3% | 31,920 | +556.8% | 0.00% | – |
| Q3 2013 | $39,000 | +2.6% | 4,860 | 0.0% | 0.00% | – |
| Q2 2013 | $38,000 | – | 4,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |